🇰🇷 South Korea Country × Condition
non small cell lung cancer Clinical Trials in South Korea
Active clinical trials for non small cell lung cancer with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 2 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇰🇷 South Korea
Active Trials in South Korea (5)
NCT07306624 Phase 2
Recruiting
Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer
Enrollment
62 pts
Country
🇰🇷 South Korea
STCube, Inc.
View Trial → NCT06841055 Phase 2
Recruiting
Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment
Enrollment
60 pts
Country
🇰🇷 South Korea
BioNTech SE
View Trial → NCT07073365 Phase 2
Recruiting
Bolstering Outcomes After Induction With Osimertinib Plus Chemotherapy Through Optimized Site-Directed Primary Tumor Therapy (BOOST Trial)
Enrollment
70 pts
Country
🇰🇷 South Korea
Pusan National University Hospital
View Trial → NCT06695845 Phase 2
Recruiting
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Enrollment
200 pts
Country
🇰🇷 South Korea
Jazz Pharmaceuticals
View Trial → NCT03791034
Recruiting
Cell Free DNA for the Diagnosis and Treatment in Early NSCLC
Enrollment
700 pts
Country
🇰🇷 South Korea
Samsung Medical Center
View Trial → Frequently Asked Questions
How many non small cell lung cancer clinical trials are active in South Korea?
There are currently 5 active clinical trials for non small cell lung cancer with sites in South Korea, of which 5 are actively recruiting patients.
How can I join a non small cell lung cancer clinical trial in South Korea?
To join a non small cell lung cancer clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are non small cell lung cancer trials in South Korea?
Active non small cell lung cancer trials in South Korea span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology